T Saldeen Selected Research

alpha-Tocopherol

4/2001

Different isoforms of tocopherols enhance nitric oxide synthase phosphorylation and inhibit human platelet aggregation and lipid peroxidation: implications in therapy with vitamin E.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T Saldeen Research Topics

Disease

2	Atherosclerosis 03/2001 - 10/2000
2	Poisoning 08/2000 - 01/2000
1	Sudden Infant Death (SID) 12/2001
1	Hypoxia (Hypoxemia) 09/2001
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2001
1	Thrombosis (Thrombus) 03/2000
1	Substance-Related Disorders (Drug Abuse) 01/2000
1	Septic Shock (Toxic Shock Syndrome) 01/2000
1	Necrosis 01/2000

Drug/Important Bio-Agent (IBA)

2	Dextropropoxyphene (Darvon)FDA LinkGeneric 08/2000 - 01/2000
1	Drinking WaterIBA 12/2001
1	NitratesIBA 12/2001
1	UreaseIBA 12/2001
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 09/2001
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2001
1	alpha-Tocopherol FDA Link 04/2001
1	P-SelectinIBA 03/2001
1	Angiotensin IIIBA 03/2001
1	AntioxidantsIBA 10/2000
1	FibrinIBA 03/2000
1	Superoxide DismutaseIBA 03/2000
1	Fish OilsIBA 03/2000
1	Thrombin FDA Link 01/2000
1	Antidepressive Agents (Antidepressants)IBA 01/2000
1	BilirubinIBA 01/2000
1	Hypnotics and Sedatives (Sedatives)IBA 01/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2000

Therapy/Procedure

1	Secondary Prevention 04/2001
1	Therapeutics 10/2000